1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow Ropivacaine 0.2% for L-ESPB: new trials by email Literature Review of Ropivacaine 0.2% for L-ESPB trials Research Report on Ropivacaine 0.2% for L-ESPB
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery Ropivacaine 0.2% for PENG Block, Ropivacaine 0.2% for LFCB, Ropivacaine 0.2% for L-ESPB - Hip Disease, Hip Dysplasia | Phase 4 | Recruiting | Poznan University of Medical Sciences | 60 | 2025-06-16 | 2025-07-11 |
Hip Dislocation (1)
Poznan University of Medical Sciences (1)
Poland (1)